Phillips Ventilators and BiPAP and CPAP and Breathing Machines Recalled Due to Health Risks
On Aug. 16, 2022 the U.S. Food and Drug Administration (FDA) issued an update on a June 2021 recall of certain ventilators, BiPAP (Bi-level Positive Airway Pressure), and CPAP (Continuous Positive Airway Pressure) breathing machines manufactured by Philips Respironics because of “potential health risks.”1 A list of the recalled devices made between 2009 and April […]
Autism Can Be a Growth Market
The title of this article should make everyone cringe. It is borrowed from an even more cringeworthy title of an article by David Feshbach that recently appeared in Barron’s financial magazine… “Autism Can Be a Growth Market, if Investors Help Scale It Up.” Clearly, there is an expectation that the autism epidemic of the past […]
South Africa Confirms Second Guillain-Barré Syndrome Death Due to COVID Vaccine
The South African Health Products Regulatory Authority (SAHPRA) confirmed on Sept. 12, 2022 that another person in South Africa has died of a polio-like neurological disorder that causes paralysis known as Guillain-Barré syndrome (GBS) due to receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. SAHPRA said the National Immunization Safety Expert Committee (NISEC) performed […]
Virginia Joins Amicus Brief to Halt COVID Vaccine Mandate in Military
On Aug. 31, 2022, Virginia Attorney General Jason Miyares added his name to an Amicus brief in a lawsuit urging the federal Fifth Circuit Court of Appeals to halt the U.S. government’s COVID-19 vaccine mandate for military personnel.1 The lawsuit was filed by 35 Navy personnel requesting religious exemption to the COVID-19 vaccine mandate. A […]
Study Reveals Much Higher Risk for Serious Adverse Events With mRNA COVID Shots in Clinical Trials
A new study published in the journal Vaccine revealed there was a much higher risk of serious adverse events of special interest for randomized clinical trial participants who received a messenger RNA (mRNA) COVID-19 biologic when compared to participants, who received a placebo for both the Pfizer/BioNTech mRNA BNT162b2 (also known as “Comirnaty”) COVID shot […]
Safety and Effectiveness of New COVID Bivalent Boosters Based on a Study of Eight Mice?
With no safety and efficacy evidence from human clinical trials, on Aug. 31, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for Pfizer/BioNTech’s Comirnaty and Moderna/NIAID’s Spikevax messenger RNA (mRNA) COVID-19 biologics to distribute “bivalent formulations” (two-in-one) of the shots to use as a “single booster dose.”1 2 The […]
